Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05171335
Title Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients
Recruitment Enrolling by invitation
Gender both
Phase Phase II
Variant Requirements No
Sponsors The Methodist Hospital Research Institute
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.